The American Cancer Society reports that surgery to remove a cancerous tumor is prescribed in 95 percent of early stage breast cancers and more than 70 percent of advanced stage breast cancers. This ...
An interview with Dr. Muriel Brackstone from London Health Sciences Centre and Dr. Tari King from Dana Farber and Brigham and Women’s Cancer Center, authors on “Management of the Axilla in Early-Stage ...
Targeted axillary dissection (TAD) is a relatively new breast cancer procedure. It allows surgical oncologists to specifically locate a lymph node that contained cancer before chemotherapy, remove it ...
Personalizing the Use of Active Surveillance As an Initial Approach for Men With Newly Diagnosed Prostate Cancer Recent findings from the American College of Surgeons Oncology Group (ACOSOG) Trial ...
Muriel Brackstone, MD, PhD; Fulvia G. Baldassarre, MSc; Francisco E. Perera, MD; Tulin Cil, MD, MEd; Mariana Chavez Mac Gregor, MD, MSc; Ian S. Dayes , MD; Jay Engel ...
Although the majority of patients with breast cancer have clinically negative axillary nodes at preoperative assessment, around 15–20% of these women will have metastatic disease within the lymph ...
Some patients who undergo these procedures will develop side effects upon the removal of the lymph nodes. Lymphedema, or a swelling of the arm and hand on the same side of the body where the lymph ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback